Atlas Trials

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Clinical trial NCT01360853 · COMPLETED

Trial details

NCT number
NCT01360853
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Pancreatic Adenocarcinoma
Start date
2011-05-01
Primary completion
2015-06-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.